ArticleMolecular therapy oncolytics2022

Intratumoral delivery of a novel oncolytic adenovirus encoding human antibody against PD-1 elicits enhanced antitumor efficacy.

Ping Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.